UB支持使纽约西部成长的癌症战斗公司

抗癌。

为罗宾创始总裁和UB教授Kate Rittenhouse-Olson于2012年推出了众多大学技术。She says that experience and the ongoing support network - which includes UB STOR, UB’s New York State Center of Excellence in Bioinformatics and Life Sciences (CBLS), and faculty and students from the university’s Jacobs School of Medicine and Biomedical Sciences – will keep her company rooted in Buffalo.

为Rittenhouse-Olson的姐姐命名为罗伯明Inc.在31岁时死于乳腺癌的姐妹。开发了一个有前途的抗体,使乳腺癌肿瘤从乳腺癌肿瘤转移到身体的其他部位。来自国家癌症研究所(NCI)的补助金,UB Bruce Holm Memorial Catalyst Fund和UB先进技术中心使公司对赛道的研究。

Rittenhouse-Olson, PhD ’84 says her most recent government grant “means we’ll be one step closer to bringing this potential therapy to patients,” and that it will allow the company to “begin testing the therapeutic possibilities of our humanized antibodies in animal cancer models.” Although the primary target is breast cancer, the antibody also has shown promise in fighting colon, prostate and bladder carcinomas.

该公司是一个成功的启动公司的一个例子,它正在建立UB的科学研究。As Congressman Brian Higgins noted when announcing the NCI’s Small Business Technology Transfer program grant, “Companies like For-Robin are an important part of Western New York’s growing life sciences economy and this award demonstrates how innovations in our region are attracting the attention of the nation’s top funding agencies.”

除了研究和种子补助金外,罗宾还获得了大学的持续指导和支持,包括企业家的帮助和UB Stor提供的两家创新实习生。Rittenhouse-Olson参加了由CBLS赞助的创业训练营,预先种子研讨会。该公司还是初创纽约州的UB附属的参与者,该计划由Gov. Andrew M. Cuomo创建的经济发展计划,允许大学识别新的和扩大企业的空间和设施,在未经支付国家的情况下运营10年,商业,公司,收入,销售或物业税或特许经营费用。为罗宾搬到南校区。